Golden Throat Holdings Group Co Ltd
06896
Company Profile
Business description
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. It manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
Contact
No. 28, Fengxiang Road
Guangxi Zhuang Autonomous Region
Liuzhou
CHNT: +86 7722825718
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
842
Stocks News & Analysis
stocks
Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount
Strong fourth quarter earnings.
stocks
Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies
We’ve raised our fair value estimate of Lilly stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,154.90 | 26.00 | -0.28% |
| CAC 40 | 8,219.36 | 42.80 | -0.52% |
| DAX 40 | 24,334.32 | 268.72 | -1.09% |
| Dow JONES (US) | 49,501.30 | 260.31 | 0.53% |
| FTSE 100 | 10,316.40 | 85.94 | -0.83% |
| HKSE | 26,885.24 | 37.92 | 0.14% |
| NASDAQ | 22,904.58 | 350.61 | -1.51% |
| Nikkei 225 | 53,818.04 | 475.32 | -0.88% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,882.72 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,889.20 | 14.80 | -0.17% |
| SSE Composite Index | 4,075.92 | 26.29 | -0.64% |